MAPT and Alzheimer disease: Furthermore, acetylation has been identified as a toxic post-translational modification of tau in the brains of AD patients (Irwin et al. 2012) and associated tauopathies patients (Min et al. 2010; Cohen et al. 2011; Cook et al. 2014).